Katie Palmer covers telehealth, clinical artificial intelligence, and the health data economy — with an emphasis on the impacts of digital health care for patients, providers, and businesses. You can reach Katie on Signal at palmer.01. AI in Neurology: A Glimpse into the Future of Brain Diagnostics The medical field is rapidly evolving, and artificial … Read more
Pharma’s People Puzzle: Trends Reshaping the Industry’s Talent Landscape The pharmaceutical industry is a dynamic ecosystem, constantly evolving with groundbreaking discoveries, fierce competition, and the ever-present need for top-tier talent. Keeping tabs on who’s coming and going, as highlighted in STAT News’s “Pharmalot” column, offers a fascinating glimpse into the strategic shifts and future directions … Read more
Health Insurance Earnings: A Rollercoaster Ride and What It Means for You The health insurance landscape is undergoing significant shifts. Recent financial reports from major players like UnitedHealth Group, Elevance, Humana, and CVS Health reveal a complex picture. Some insurers are scaling back their profit forecasts, while others are experiencing gains. This volatility isn’t just … Read more
The FDA’s Shifting Sands: Analyzing Dr. Prasad’s Departure and What It Means for the Future The recent departure of a key figure from the Food and Drug Administration (FDA), Dr. Vinay Prasad, sent ripples through the biotech and pharmaceutical industries. His exit, amidst controversies surrounding decisions on a treatment for Duchenne muscular dystrophy, highlights evolving … Read more
Alzheimer’s Treatment Landscape: Shifting Tides and Future Horizons The recent shift in the European Medicines Agency’s (EMA) stance on Eli Lilly’s Alzheimer’s treatment, Kisunla, highlights a critical turning point in the ongoing battle against this devastating disease. What was initially a rejection has evolved into a conditional approval, emphasizing the complex interplay of risk assessment, … Read more
The Shifting Sands of Drug Development: Navigating Uncertainties in the Biotech Landscape Hello, fellow health enthusiasts and industry observers! Allison here, back with you to dissect the latest tremors shaking the pharmaceutical world. The news cycle has been particularly active, and the stakes are high. Let’s dive into the key developments and explore what these … Read more
The Future is Now: Navigating the Convergence of Pharma, Telehealth, and Health Tech Hello health tech enthusiasts! As your friendly neighborhood industry insider, I’m here to dissect the exciting, and sometimes turbulent, intersection of pharmaceuticals, telehealth, and the ever-evolving world of health technology. The landscape is changing rapidly, and staying informed is critical. Let’s dive … Read more
Medicaid Funding Cuts Loom: What Banner Health’s Situation Reveals As the healthcare landscape continues to evolve, understanding the financial pressures faced by major healthcare providers is more crucial than ever. The recent disclosure from Banner Health, a 33-hospital system, highlights a significant challenge on the horizon: potential cuts to Medicaid funding. This situation isn’t unique … Read more
Navigating the Future: Emerging Trends in Pharmaceuticals and Drug Pricing The pharmaceutical landscape is constantly evolving, driven by groundbreaking scientific advancements, complex regulatory changes, and the ever-present pressure of drug pricing. Understanding these trends is crucial for investors, healthcare professionals, and anyone concerned with the future of medicine. Let’s delve into some key areas shaping … Read more
Revolutionizing Type 1 Diabetes Treatment: A Look at Obesity Drugs The world of diabetes management is constantly evolving. For years, the focus has been on controlling blood sugar levels. But now, a groundbreaking approach is gaining traction: using obesity drugs to help manage type 1 diabetes. This shift could potentially transform the lives of millions. … Read more